While tumor BCR clones were present in all blood samples of patient #419, they only accounted for 0.18%, 1.4%, 0.2%, and 1.4% of the total peripheral BCR IR at TP1, TP2, TP3, and TP4, respectively. This evidence concerns the gene BCR and neoplasm.